SNES WACC - Weighted Average Cost of Capital
The WACC of Senestech Inc (SNES) is 6.5%.
| Range | Selected | |
| Cost of equity | 5.7% - 7.4% | 6.55% |
| Tax rate | 26.2% - 27.0% | 26.6% |
| Cost of debt | 7.0% - 7.0% | 7% |
| WACC | 5.6% - 7.3% | 6.5% |
| Category | Low | High |
| Long-term bond rate | 3.9% | 4.4% |
| Equity market risk premium | 4.6% | 5.6% |
| Adjusted beta | 0.39 | 0.45 |
| Additional risk adjustments | 0.0% | 0.5% |
| Cost of equity | 5.7% | 7.4% |
| Tax rate | 26.2% | 27.0% |
| Debt/Equity ratio | 0.05 | 0.05 |
| Cost of debt | 7.0% | 7.0% |
| After-tax WACC | 5.6% | 7.3% |
| Selected WACC | 6.5% | |
| Debt/Equity | Unlevered | |||
| Peers | Company Name | ratio | Beta | beta |
| SNES | Senestech Inc | 0.05 | 1.75 | 1.69 |
| BSPK | Bespoke Extracts Inc | 0.7 | 1.28 | 0.85 |
| CPMD | CannaPharmaRx Inc | 3.21 | -0.6 | -0.18 |
| GNOM.CN | Gnomestar Craft Inc | 2.36 | 1.84 | 0.68 |
| IPCI.TO | Intellipharmaceutics International Inc | 1.06 | -0.25 | -0.14 |
| KAYS | Kaya Holdings Inc | 5.13 | 0.94 | 0.2 |
| MJ.CN | True Leaf Brands Inc | 8.68 | 1.01 | 0.14 |
| MLCL.CN | Molecule Holdings Inc | 10.9 | 1.39 | 0.15 |
| RPRX | Royalty Pharma PLC | 0.4 | 0.02 | 0.01 |
| ULUR | ULURU Inc | 0.09 | 1.62 | 1.52 |
| Low | High | |
| Unlevered beta | 0.15 | 0.39 |
| Relevered beta | 0.09 | 0.18 |
| Adjusted relevered beta | 0.39 | 0.45 |
SNES's CAPM model and how its cost of Equity is calculated
The Cost of Equity reflects the return a company needs to deliver to shareholders to justify the risk of investing in its shares. It’s computed using the Capital Asset Pricing Model (CAPM), which blends the risk-free rate, the stock’s beta, and the market risk premium.
This method evaluates the stock’s risk compared to a safe investment and the market’s overall volatility.
Here’s how we figure out the cost of equity for SNES:
cost_of_equity (6.55%) = risk_free_rate (4.15%) + equity_risk_premium (5.10%) * adjusted_beta (0.39) + risk_adjustments (0.25%)
We include the risk adjustments, which range from 0% to 1%, to keep our WACC conservatives, especially for companies traded in developing markets.